ABSTRACT
In the advanced Parkinson's disease, motor and non-motor symptoms become more severe and more difficult to treat. Oral therapy may become insufficient in controlling a patient´s motor complications, which results in a substantial deterioration of the patient's quality of life, ability to work and self-reliance. This is when device-aided treatments should be considered and offered, if suitable for a given patient. They include subcutaneous and intestinal infusion therapies, deep brain stimulation and, more recently, MRI-guided focussed ultrasound. Device-aided treatments should be offered in accordance with guidelines and treatment standardization. Also there is a need to ensure availability of treatment and education of patients and physicians.
Subject(s)
Deep Brain Stimulation , Parkinson Disease , Humans , Parkinson Disease/diagnostic imaging , Parkinson Disease/therapy , Antiparkinson Agents , Levodopa , Carbidopa , Quality of Life , Deep Brain Stimulation/methods , Drug CombinationsSubject(s)
Aphasia, Primary Progressive , Frontotemporal Dementia , Parkinsonian Disorders , Humans , Mutation/genetics , Parkinsonian Disorders/diagnostic imaging , Parkinsonian Disorders/genetics , Aphasia, Primary Progressive/diagnostic imaging , Aphasia, Primary Progressive/genetics , Progranulins/geneticsABSTRACT
Cerebral venous sinus thrombosis (CVST) is a relatively rare condition. We present a case of an acute aseptic thrombosis of the sagittal, transverse and sigmoid sinus in a puerperium patient with protein S deficiency. The specifics of the case include high intracranial pressure (ICP) caused by sinus thrombosis with typical symptomatology and bilateral papilloedema, which also manifested in transient bilateral abducens nerve palsy and, consequently, bilateral horizontal diplopia. The recovery of the cranial nerve function occurred 3 to 4 weeks after it was initially reported. Prompt and adequate anticoagulant therapy contributed to the almost complete recanalization of the dural venous sinus thrombosis and a positive outcome of the disease.